Teradyne director Marilyn Matz plans $140K sale
The 400 shares are identified as compensation from restricted-stock vesting on May 9, 2024; four prior sales are also listed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Teradyne, Inc. director Marilyn Matz reported an intended sale of 400 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $140,000.00 and an approximate sale date of October 21, 2026. The shares are listed as compensation from restricted-stock vesting on May 9, 2024. The notice also lists four sales in the preceding three months: 1,200 shares on August 17, 800 on September 15, 400 on September 17, and 800 on October 15, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Rule 144 regulatory
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.